Evidence map›Paper›PMID 35185345›Full record

ReviewClinical medicine insights. Arthritis and musculoskeletal disorders2022

Musculoskeletal Manifestations of Sarcoidosis.

Georges El Hasbani, Imad Uthman, Ali Sm Jawad

Open access · goldAbstract readReview
In one paragraph

Review in Clinical medicine insights. Arthritis and musculoskeletal disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Rheumatic Manifestations of Sarcoidosis.Diagnostics (Basel, Switzerland) · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Safety of corticosteroid therapy in sarcoidosis treatment.Frontiers in drug safety and regulation · 2023
    Review
  8. Article
  9. Decoding sarcoidosis chronicity through phenotypic profiling.Therapeutic advances in respiratory disease
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Georges El HasbaniDepartment of Internal Medicine, St. Vincent's Medical Center, Bridgeport, CT, USA.ORCID https://orcid.org/0000-0003-2571-1450
Imad UthmanDepartment of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.ORCID https://orcid.org/0000-0001-8285-6483
Ali Sm JawadDepartment of Rheumatology, The Royal London Hospital, London, UK.
American University of Beirut Medical Center · LBRoyal London Hospital · GBSt. Vincent's Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since its initial description in the late 19th century, sarcoidosis has been extensively studied. Although the general mechanism of immune activation is known, many details especially in the context of disease associations are still missing. One of such associations is the musculoskeletal complications that are widely variable in terms of presentation and response to treatment. Sarcoidosis can involve the joints leading to acute and, less commonly chronic, arthritis. While acute arthritis is mostly self-resolving in nature, chronic arthritis may lead to deformity and destruction of the joint. Sarcoidosis can also involve the muscles, leading to different pathologies primarily categorized according to the clinical presentation, despite the efforts to find a new classification based on imaging, histological, and clinical findings. The bones can be directly and indirectly affected. Different types of bone lesions have been described, although around half of these patients remain asymptomatic. Osteoporosis, increased risk of fractures, hypercalcemia, and hypercalciuria are examples of the indirect effect of sarcoidosis on the bones, possibly contributed to elevated levels of calcitriol. Nevertheless, sarcoidosis can be associated with small-vessel, medium-vessel, and large vessel vasculitis, although it is frequently difficult to differentiate between the co-existence of a pure vasculitis and sarcoidosis and sarcoid vasculitis.

Indexed as

bonesjointsmusclespathologySarcoidosistreatmentvessels

Identifiers

PMID35185345
PMCPMC8854226
OpenAlexW4213346156

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.